SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-197705
Filing Date
2023-07-28
Accepted
2023-07-28 16:09:04
Documents
13
Period of Report
2023-07-24
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d515262d8k.htm   iXBRL 8-K 32529
2 EX-3.1 d515262dex31.htm EX-3.1 5801
  Complete submission text file 0001193125-23-197705.txt   166115

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA veru-20230724.xsd EX-101.SCH 2848
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE veru-20230724_lab.xml EX-101.LAB 18740
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE veru-20230724_pre.xml EX-101.PRE 11706
7 EXTRACTED XBRL INSTANCE DOCUMENT d515262d8k_htm.xml XML 3541
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-13602 | Film No.: 231123096
SIC: 2834 Pharmaceutical Preparations